Abstract:Type-I transmembrane Toll-like receptors (TLRs) are central to host defense against pathogens. Of the ten human TLRs, TLR4 is of particular interest given the complex mechanism required to recognize lipopolysaccharide (LPS) from the outer membranes of Gram-negative bacteria, culminating in transfer of LPS by membrane-bound CD14 to TLR4 in complex with the MD-2 coreceptor. Atomically detailed and enhanced sampling molecular simulations have recently enabled us to identify the allosteric switch in TLR4 activation; key to the switching mechanism is the remarkable conformational plasticity of the coreceptor, which we show is functionally conserved across an entire family of lipid recognition domains. As well as unravelling the experimentally-established structure-activity relationships of natural and synthetic LPS derivatives, we have combined simulations with biochemical data for TLR4 interaction with dietary fatty acids, challenging the long-accepted notion that the link between obesity, chronic inflammation, and insulin resistance occurs via this receptor. Related approaches have uncovered the mechanisms by which LPS derivatives are transferred from bacterial LPS aggregates to the CD14 coreceptor, and identified both the dynamic gating mechanism and final bound state of a hypothesized amino-terminal pocket, consistent with available NMR data. Finally, we have constructed multiscale models of truncated and full-length receptor libraries spanning the human TLR family, enabling observation of their transmembrane oligomerization. We correlate this with in vitro association and acceptor photobleaching FRET data for dimerization within live cells, helping to identify key stabilizing motifs and rationalize disruptive mutations. Our results reveal the structural basis for the tight coupling between extracellular, transmembrane, and intracellular domains required for higher order assembly, conformational change and adaptor recruitment. Collectively, these studies extend our mechanistic understanding of membrane receptor function, and pave the way for novel immunomodulatory therapeutic approaches.

Select Targeting of Intracellular Toll-interleukin-1 Receptor Resistance Domains for Protection Against Influenza-Induced Disease.

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

Establishing the Structural Rules for Ligand Recognition, Signaling and Assembly in Innate Immune Receptors

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Molecular Mechanisms for the Subversion of Myd88 Signaling by Tcpc from Virulent Uropathogenic Escherichia Coli

Identification of Lps2 As a Key Transducer of MyD88-independent TIR Signalling.

The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung

Modulation of Toll–interleukin 1 receptor mediated signaling

Bacterial TIR-containing proteins and host innate immune system evasion

The Θ-Defensin Retrocyclin 101 Inhibits TLR4- and TLR2-dependent Signaling and Protects Mice Against Influenza Infection.

Damage sensing through TLR9 Regulates Inflammatory and Antiviral Responses During Influenza Infection

Forward Genetic Analysis of TLR Pathways

Inhibition of TLR4 signaling by Brucella TIR-containing protein TcpB-derived decoy peptides

Sending Innate Immune Signals Across the Membrane: A Multiscale Simulation Approach to Toll-Like Receptor Assembly

A Polar SxxS Motif Drives Assembly of the Transmembrane Domains of Toll-like Receptor 4.

Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling

Genetic analysis of innate immunity: identification and function of the TIR adapter proteins.

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

Damage sensing through TLR9 Promotes Viral Clearance and Recovery During Influenza Infection

Structural Basis of the IL-1 Receptor TIR Domain-Mediated IL-1 Signaling

Structural insights into the role of deleterious mutations at the dimeric interface of Toll-like receptor interferon-β related adaptor protein